Lumbosacral radicular pain market to reach $1.28 billion by 2030 at 5.7% CAGR, driven by increasing prevalence of degenerative spinal conditions and rising prevalence of obesity.
Read More
Modular fill-finish micro-factory market to reach $2.96 billion by 2030 at 11.1% CAGR, driven by increasing demand for personalized medicines.
Read More
Losartan potassium active pharmaceutical ingredient (api) market to reach $2.54 billion by 2030 at 6.5% CAGR, driven by growing prevalence of hypertension.
Read More
Minimal residual disease testing market to reach $3.31 billion by 2030 at 13.1% CAGR, driven by increasing prevalence of cancer.
Read More
Local anesthesia drugs market to reach $6.15 billion by 2030 at 5.6% CAGR, driven by increase in prevalence of chronic diseases.
Read More
Liver health supplements market to reach $14.82 billion by 2030 at 6.3% CAGR, driven by rising consumption of alcohol and increasing prevalence of chronic liver diseases.
Read More
Mineral supplements market to reach $24.28 billion by 2030 at 6.3% CAGR, driven by increased sports and fitness activities.
Read More
Liver cancer therapeutics market to reach $6.34 billion by 2030 at 16.5% CAGR, driven by rise in incidence of hepatitis b infections.
Read More
Milk protein concentrate market to reach $4.25 billion by 2030 at 6.9% CAGR, driven by rising demand for high-protein foods.
Read More
The global migraine drugs market to reach $7.47 billion by 2030 at 5.5% CAGR, driven by increase in prevalence of migraine.
Read More